Liwei Wang
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Surgery
- Topics
- CAR-T cell therapy research (10 papers)Pancreatic and Hepatic Oncology Research (9 papers)Colorectal Cancer Treatments and Studies (8 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Liwei Wang
50 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 659
- Molecular Biology 448
- Pulmonary and Respiratory Medicine 442
- Cancer Research 273
- Surgery 216
Countries citing papers authored by Liwei Wang
This map shows the geographic impact of Liwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Wang more than expected).
Fields of papers citing papers by Liwei Wang
This network shows the impact of papers produced by Liwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Wang. The network helps show where Liwei Wang may publish in the future.
Co-authorship network of co-authors of Liwei Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Wang. A scholar is included among the top collaborators of Liwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Wang. Liwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 3 | |
| 9 | 172 | |
| 10 | 4 | |
| 11 | 58 | |
| 12 | 31 | |
| 13 | 14 | |
| 14 | 63 | |
| 15 | Collect at Once, Use Effectively: Making Non-interactive Locally Private Learning Possible | 2 |
| 16 | 11 | |
| 17 | 3 | |
| 18 | 139 | |
| 19 | 7 | |
| 20 | 66 |
About Liwei Wang
Liwei Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). The work is most often cited by research in Oncology (659 citations), Cancer Research (273 citations) and Gastroenterology (93 citations). Liwei Wang has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Jianming Xu, Yuxian Bai, Shukui Qin, Jianping Xiong, Zhehai Wang, Nong Xu, Guoping Sun, Leizhen Zheng, Weijian Guo and Yan Yang. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.